Sensei Biotherapeutics KOL Event on VISTA: A Suppressor of T-Cells

Back to Events


Join us for the Sensei Biotherapeutics KOL Event, featuring Robert Schreiber, PhD (Washington University School of Medicine) who will provide background on VISTA (V-domain Immunoglobulin Suppressor of T cell Activation) and discuss the unmet medical needs present in the current immuno-oncology treatment landscape, and the importance of VISTA in developing highly selective therapeutics.

The Sensei Biotherapeutics leadership team will provide an overview of its conditionally active and fully human antibody, SNS-101, including a review of new preclinical data. Using its TMAb™ platform, Sensei’s SNS-101 is being developed to selectively block the VISTA checkpoint within a low pH tumor microenvironment.

A live Q&A session will follow the formal presentations.

The post Sensei Biotherapeutics KOL Event on VISTA: A Suppressor of T-Cells appeared first on LifeSci Events.